Artemis Wealth Advisors’s Dare Bioscience DARE Stock Holding History

Artemis Wealth Advisors’s Portfolio DARE Stock Details DARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-73	Closed	-$1.08K	–	109
2022 Q2	$1.08K	Hold	73	–	–	﹤0.01%	118
2022 Q1	$1.31K	Hold	73	–	–	﹤0.01%	58
2021 Q4	$1.76K	Hold	73	–	–	﹤0.01%	69
2021 Q3	$1.47K	Hold	73	–	–	﹤0.01%	76
2021 Q2	$1.67K	Hold	73	–	–	﹤0.01%	73
2021 Q1	$1.49K	Hold	73	–	–	﹤0.01%	76
2020 Q4	$1.18K	Hold	73	–	–	﹤0.01%	60
2020 Q3	$880	Hold	73	–	–	﹤0.01%	80
2020 Q2	$871	Hold	73	–	–	﹤0.01%	55
2020 Q1	$749	Hold	73	–	–	﹤0.01%	61
2019 Q4	$722	Hold	73	–	–	﹤0.01%	122
2019 Q3	$677	Hold	73	–	–	﹤0.01%	29
2019 Q2	$749	Hold	73	–	–	﹤0.01%	29
2019 Q1	$1.23K	Hold	73	–	–	﹤0.01%	29
2018 Q4	$617	Hold	73	–	–	﹤0.01%	41
2018 Q3	$859	Hold	73	–	–	﹤0.01%	29
2018 Q2	$1.03K	Hold	73	–	–	﹤0.01%	29
2018 Q1	$738	Hold	73	–	–	﹤0.01%	30
2017 Q4	$1.9K	Hold	73	–	–	﹤0.01%	26
2017 Q3	$2.75K	Hold	73	–	–	﹤0.01%	25
2017 Q2	$3.91K	Hold	73	–	–	﹤0.01%	22
2017 Q1	$7.16K	Hold	73	–	–	0.01%	32
2016 Q4	$6K	Buy	+73	New	+$6.96K	0.01%	28

Other funds holding DARE

FFS

Founders Financial Securities Towson, Maryland $1.77B AUM 17.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SAM

Soviero Asset Management New York $200M AUM 134.59% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Artemis Wealth Advisors's DARE Position: Q3 2022 in Review

Artemis Wealth Advisors sold out of Dare Bioscience (DARE) in Q3 2022, closing a stake of 73 shares — an estimated $1.08K sold.

Artemis Wealth Advisors first reported a position in DARE in Q4 2016 and held it in 23 quarters. The position peaked at $7.16K in Q1 2017. 31 funds tracked by Wall St. Rank hold DARE as of Q3 2022.

Artemis Wealth Advisors reported no remaining Dare Bioscience position as of Q3 2022 after selling out during the quarter.
Artemis Wealth Advisors sold 73 Dare Bioscience shares in Q3 2022, an estimated $1.08K.
Artemis Wealth Advisors first reported a position in Dare Bioscience in Q4 2016 and held it in 23 quarters.
Artemis Wealth Advisors's Dare Bioscience position peaked at $7.16K in Q1 2017.
31 funds tracked by Wall St. Rank held Dare Bioscience as of Q3 2022.

Based on Artemis Wealth Advisors's 13F filing for Q3 2022, filed 24 Oct 2022.